Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/27/2000 | EP1038868A2 Sulfonamides as antiviral agents |
09/27/2000 | EP1038530A2 Immunomodulator comprising DNA |
09/27/2000 | EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis |
09/27/2000 | EP1038037A1 Screening assays for the detection and diagnosis of influenza virus |
09/27/2000 | EP1038019A1 NOVEL ribB |
09/27/2000 | EP1038016A2 Needle-free injection of formulated nucleic acid molecules |
09/27/2000 | EP1038001A2 Constitutive expression of non-infectious hiv-like particles |
09/27/2000 | EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection |
09/27/2000 | EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides |
09/27/2000 | EP1037998A1 guaA POLYPEPTIDES |
09/27/2000 | EP1037995A1 Human interferon-epsilon: a type 1 interferon |
09/27/2000 | EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
09/27/2000 | EP1037924A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
09/27/2000 | EP1037917A1 Recombinant nodavirus compositions and methods |
09/27/2000 | EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs |
09/27/2000 | EP1037905A1 Antipicornaviral compounds and methods for their use and preparation |
09/27/2000 | EP1037903A1 Peptide-based gemini compounds |
09/27/2000 | EP1037887A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
09/27/2000 | EP1037669A1 Therapeutic use of lentiviral vectors |
09/27/2000 | EP1037664A1 Vaccines containing attenuated bacteria |
09/27/2000 | EP1037661A1 ribH |
09/27/2000 | EP1037660A1 ribB |
09/27/2000 | EP1037658A1 Ifnar2/ifn complex |
09/27/2000 | EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
09/27/2000 | EP1037652A1 Pharmaceutical compositions based on dalforpristin and quinupristin and preparation |
09/27/2000 | EP1037650A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
09/27/2000 | EP1037640A2 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
09/27/2000 | EP1037639A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
09/27/2000 | EP1037638A1 Agents |
09/27/2000 | EP1037636A1 Inhibition of membrane-associated viral replication |
09/27/2000 | EP1037635A1 Compounds and methods |
09/27/2000 | EP1037633A1 Antiviral compounds |
09/27/2000 | EP1037614A2 A double capsule for the administration of active principles in multiple therapies |
09/27/2000 | EP1037610A1 Liposomal camptothecin formulations |
09/27/2000 | EP1037530A1 ribG |
09/27/2000 | EP1037529A1 Composition useful for providing one-step surgical preparation and drape |
09/27/2000 | EP1005351A4 An aqueous metal bicarbonate solution and method of use |
09/27/2000 | EP0754055B1 Group a streptococcal polysaccharide immunogenic compositions and methods |
09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
09/27/2000 | EP0612216B1 Phospholipid antimicrobial compositions |
09/27/2000 | CN1268172A Novel lactic acid bacteria |
09/27/2000 | CN1268140A Monocyclic L-nucleosides, analogs and uses thereof |
09/27/2000 | CN1268135A Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
09/27/2000 | CN1268055A Pharmaceutical suspension comprising nevirapine hemihydrate |
09/27/2000 | CN1267519A Immune regulator, immune regulator food and immune regulator fodder |
09/27/2000 | CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
09/27/2000 | CN1056876C Cultivation method for preparing oral live typhoidvaccine |
09/27/2000 | CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy |
09/27/2000 | CN1056847C 7-acyl-3-(substd. carbamoyloxy) cephem compounds and their preparation process |
09/27/2000 | CN1056824C Improved synthesis of cyclopropylacetylene |
09/27/2000 | CN1056774C 'Keyoulin' sterilizing agent |
09/27/2000 | CN1056751C Zhishiqingjie injecta |
09/26/2000 | US6124494 Anti-viral compounds |
09/26/2000 | US6124450 Processes and intermediates for phosphorous-containing covalent linkages |
09/26/2000 | US6124432 Bringing dermonecrotic toxin-containing solution into contact with chromatographic gel sulfated by direct sulfation or a chromatographic gel to which a sulfated molecule is covalently bonded to thereby adsorb dermonecrotic toxin on gel, eluting |
09/26/2000 | US6124352 Antifungal agents |
09/26/2000 | US6124325 Triazole antifungal agents |
09/26/2000 | US6124324 An enzyme inhibitor of reverse transcriptase for the treatment of hiv infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of hiv |
09/26/2000 | US6124320 Treating with non-sedating antihistamines without causing cardiac arrhythmias |
09/26/2000 | US6124307 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof |
09/26/2000 | US6124306 Treating human immunodeficiency virus infections |
09/26/2000 | US6124290 Treating bacterial infections |
09/26/2000 | US6124288 Phosphodiesterase iv inhibitors |
09/26/2000 | US6124271 Method and conjugate for treating H. pylori infection |
09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
09/26/2000 | US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic |
09/26/2000 | US6123943 NF-KB activity inhibitor |
09/26/2000 | CA2200069C Anti-fungal peptides |
09/26/2000 | CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
09/26/2000 | CA2018461C Novel polypeptides and their use |
09/21/2000 | WO2000055621A2 Blood leucocyte apheresis for treatment of disease |
09/21/2000 | WO2000055371A1 27 human secreted proteins |
09/21/2000 | WO2000055352A2 50 human secreted proteins |
09/21/2000 | WO2000055344A1 Adenoviral vector expressing a sv40 t antigen antisense rna |
09/21/2000 | WO2000055341A1 Anti-viral vectors |
09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |
09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
09/21/2000 | WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection |
09/21/2000 | WO2000055199A1 47 human secreted proteins |
09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
09/21/2000 | WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins |
09/21/2000 | WO2000055186A1 Antibiotic wap-2607b, process for producing the same and antibacterial agents |
09/21/2000 | WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains |
09/21/2000 | WO2000055171A1 50 human secreted proteins |
09/21/2000 | WO2000055168A1 6-o-substituted macrolides having antibacterial activity |
09/21/2000 | WO2000055159A2 Substituted aza-oxindole derivatives |
09/21/2000 | WO2000055153A1 Amide derivatives |
09/21/2000 | WO2000055150A1 Improved process for asymmetric hydrogenation |
09/21/2000 | WO2000055149A1 Dimeric compounds and as inhibitors of neuraminidase |
09/21/2000 | WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
09/21/2000 | WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
09/21/2000 | WO2000055112A1 Anti-viral compounds |
09/21/2000 | WO2000055072A2 Aerosol metering valve |
09/21/2000 | WO2000054811A1 Medicinal compositions |
09/21/2000 | WO2000054802A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
09/21/2000 | WO2000054800A1 Preventives/remedies for digestive diseases |
09/21/2000 | WO2000054792A1 Drugs, foods, drinks and feeds containing cocoa component |
09/21/2000 | WO2000054789A1 Bacterial membrane fractions with adjuvant effect |